Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study (Q34329113)

1 August 2017

title

Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study (English)

1 reference

1 August 2017

0 references

1 reference

7

David St Clair

1 reference

1 August 2017

Mingqing Xu

1

1 reference

1 August 2017

Sheng Li

2

1 reference

1 August 2017

Qinghe Xing

3

1 reference

1 August 2017

Rui Gao

4

1 reference

1 August 2017

Guoyin Feng

5

1 reference

1 August 2017

Zhiguang Lin

6

1 reference

1 August 2017

Lin He

8

1 reference

1 August 2017

publication date

20 January 2010

1 reference

European Journal of Human Genetics

1 August 2017

published in

1 reference

1 August 2017

volume

18

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

707-712

1 reference

https://scigraph.springernature.com/pub.10.1038/ejhg.2009.238

1 August 2017

exact match

0 references

cites work

Pharmacoepigenetics: its role in interindividual differences in drug response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

BDNF Val66Met variant and age of onset in schizophrenia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Interaction between BDNF and serotonin: role in mood disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Heterogeneity of treatment effects in schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Haploview: analysis and visualization of LD and haplotype maps

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

A powerful strategy to account for multiple testing in the context of haplotype analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

A New Statistical Method for Haplotype Reconstruction from Population Data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

6 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Therapeutic options for modifying cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2009.238

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987331

Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study

27 October 2018

1 reference

12 December 2020

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison

1 reference

12 December 2020

Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients

1 reference

12 December 2020

Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia

1 reference

12 December 2020

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia

1 reference

12 December 2020

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/EJHG.2009.238

1 reference

1 August 2017

1 reference

1 August 2017

1 reference